secwatch.observer — SEC 8-K summary
======================================

Issuer:     Jasper Therapeutics, Inc. (JSPR)
CIK:        0001788028
Form:       8-K
Filed at:   2022-11-04T23:59:59+00:00
Accession:  0001213900-22-069368
Event type: regulatory
Sentiment:  negative
Materiality: 0.65
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Jasper Therapeutics receives Nasdaq deficiency notice for bid price below $1.00
-------------------------------------------------------------------------------

- Nasdaq notice on Nov 3, 2022: bid price below $1.00 for 30 consecutive business days.
- Company has 180 days (until May 2, 2023) to regain compliance by closing at $1.00+ for 10 consecutive days.
- No immediate impact on listing; JSPR and JSPRW continue trading on Nasdaq Capital Market.
- Options include reverse stock split if needed; company intends to monitor and consider available options.
- Failure to cure may lead to delisting; possible appeal process but no assurance of relief.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1788028/000121390022069368/0001213900-22-069368-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1788028/000121390022069368/ea168052-8k_jasperthera.htm
  HTML page:      https://secwatch.observer/filing/0001213900-22-069368

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer